2ING | Dna Binding Protein | date | Oct 07, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | X-Ray Structure Of The Brca1 Brct Mutant M1775k | ||||||||||||||
authors | G.Birrane, A.Soni, J.A.A.Ladias | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Breast Cancer Type 1 Susceptibility Protein Chain: X Fragment: Brct1, Brct2 Synonym: Ring Finger Protein 53 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Brca1, Rnf53 Expression_system: Escherichia Coli Bl21 Expression_system_taxid: 511693 Expression_system_strain: Bl21 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pmal-C2x | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.60 Å | ||||||||||||
ligand | CO, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach., Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD, Eur J Hum Genet. 2008 Feb 20;. PMID:18285836 |
Data retrieval |
View 2ING in 3D |
Visual 3D analysis of 2ING |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2ING |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |